Anticoagulants: A Short History, Their Mechanism of Action, Pharmacology, and Indications

被引:47
作者
Heestermans, Marco [1 ,2 ]
Poenou, Geraldine [2 ,3 ]
Hamzeh-Cognasse, Hind [2 ]
Cognasse, Fabrice [1 ,2 ]
Bertoletti, Laurent [2 ,3 ,4 ]
机构
[1] French Blood Estab EFS Auvergne Rhone Alpes Sci D, F-42270 St Etienne, France
[2] Jean Monnet Univ, SAINBIOSE, U1059, INSERM, F-42023 St Etienne, France
[3] CHU St Etienne, Serv Med Vasc & Therapeut, F-42055 St Etienne, France
[4] CHU St Etienne, INSERM, CIC 1408, F-42055 St Etienne, France
关键词
venous thromboembolism; anticoagulant drugs; heparin; vitamin K antagonists; DOACs; pharmacology; drug-drug interactions; novel anticoagulants; MOLECULAR-WEIGHT HEPARIN; DIRECT ORAL ANTICOAGULANTS; DRUG-DRUG INTERACTIONS; FACTOR-XA; VITAMIN-K; VENOUS THROMBOEMBOLISM; UNFRACTIONATED HEPARIN; THROMBIN INHIBITOR; INDUCED THROMBOCYTOPENIA; PLASMA-PROTEINS;
D O I
10.3390/cells11203214
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Anticoagulant drugs antagonize coagulation and are used to prevent or cure (recurrent) venous thromboembolism (VTE). Drugs to prevent clotting have been used for more than a century, and, nowadays, physicians possess a broad panel of multiple anticoagulants to meet the individual needs of a patient. Within this review, we aimed to revise the history of the different anticoagulants that are currently prescribed in the clinic. In addition, we compared their pharmacological properties, medical indications, and the difficulties in implementing new anticoagulants in vulnerable patient populations. Since the introduction of unfractionated heparin in the 1930s, major advances in the mechanistic understanding and the medical use of anticoagulants have allowed for significant improvements to treat VTE patients. However, a new generation of anticoagulants is currently being tested in clinical trials, with the goal of further optimizing medical care.
引用
收藏
页数:17
相关论文
共 116 条
  • [1] HIGHLY PURIFIED ANTITHROMBIN 3 WITH HEPARIN COFACTOR ACTIVITY PREPARED BY DISC ELECTROPHORESIS
    ABILDGAARD, U
    [J]. SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1968, 21 (01) : 89 - +
  • [2] Characteristics and Management of Patients with Venous Thromboembolism: The GARFIELD-VTE Registry
    Ageno, Walter
    Haas, Sylvia
    Weitz, Jeffrey, I
    Goldhaber, Samuel Z.
    Turpie, Alexander G. G.
    Goto, Shinya
    Angchaisuksiri, Pantep
    Nielsen, Joern Dalsgaard
    Kayani, Gloria
    Pieper, Karen S.
    Schellong, Sebastian
    Bounameaux, Henri
    Mantovani, Lorenzo G.
    Prandoni, Paolo
    Kakkar, Ajay K.
    Loualidi, Abdelelah
    Colak, Abdurrahim
    Bezuidenhout, Abraham
    Abdool-Carrim, Abu
    Azeddine, Addala
    Beyers, Adriaan
    Dees, Adriaan
    Cheong, Adrian Piers Yan Yue
    Mohamed, Ahmed
    Aksoy, Ahmet
    Abiko, Akihiko
    Watanabe, Akinori
    Krichell, Alan
    Alfredo Fernandez, Alberto
    Tosetto, Alberto
    Khotuntsov, Alexey
    Slocombe, Alison
    Kelly, Allan
    Clark, Amanda
    Gad, Amr
    Schmidt, Andor
    Berni, Andrea
    Kleiban, Andres Javier
    Machowski, Andrew
    Kazakov, Andrey
    Lockman, Ann
    Falanga, Anna
    Riera-Mestre, Antoni
    Mazzone, Antonino
    Chauhan, Anoop
    D'Angelo, Armando
    Herdy, Artur Haddad
    Al Ghoul, Ashraf
    Kato, Atsushi
    Ebrahim, Ayman Abd Elhamid
    [J]. THROMBOSIS AND HAEMOSTASIS, 2019, 119 (02) : 319 - 327
  • [3] AMIRAL J, 1992, THROMB HAEMOSTASIS, V68, P95
  • [4] The process of structure-based drug design
    Anderson, AC
    [J]. CHEMISTRY & BIOLOGY, 2003, 10 (09): : 787 - 797
  • [5] Concurrent Use of Warfarin and Antibiotics and the Risk of Bleeding in Older Adults
    Baillargeon, Jacques
    Holmes, Holly M.
    Lin, Yu-Li
    Raji, Mukaila A.
    Sharma, Gulshan
    Kuo, Yong-Fang
    [J]. AMERICAN JOURNAL OF MEDICINE, 2012, 125 (02) : 183 - 189
  • [6] Comparison of bivalirudin to lepirudin and argatroban in patients with heparin-induced thrombocytopenia (Reprinted from Journal of Health-System Pharmacy Residents JHPR, vol 1, issue 4, 2013)
    Bain, Jonathan
    Meyer, Andrew
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2015, 72 (17) : S104 - S109
  • [7] Direct Oral Anticoagulants in Patients with Liver Disease in the Era of Non-Alcoholic Fatty Liver Disease Global Epidemic: A Narrative Review
    Ballestri, Stefano
    Capitelli, Mariano
    Fontana, Maria Cristina
    Arioli, Dimitriy
    Romagnoli, Elisa
    Graziosi, Catia
    Lonardo, Amedeo
    Marietta, Marco
    Dentali, Francesco
    Cioni, Giorgio
    [J]. ADVANCES IN THERAPY, 2020, 37 (05) : 1910 - 1932
  • [8] BINDING AND ENDOCYTOSIS OF HEPARIN BY HUMAN-ENDOTHELIAL CELLS IN CULTURE
    BARZU, T
    MOLHO, P
    TOBELEM, G
    PETITOU, M
    CAEN, J
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1985, 845 (02) : 196 - 203
  • [9] BELL RG, 1978, FED PROC, V37, P2599
  • [10] The Effects of the Combined Argatroban/Nitric Oxide-Releasing Polymer on Platelet Microparticle-Induced Thrombogenicity in Coated Extracorporeal Circuits
    Bellomo, Tiffany R.
    Jeakle, Mark A.
    Meyerhoff, Mark E.
    Bartlett, Robert H.
    Major, Terry C.
    [J]. ASAIO JOURNAL, 2021, 67 (05) : 573 - 582